Background: Multi-modal brain image registration is a prerequisite for accurate mapping of brain structure and function in neuroscience. Image registration is commonly performed using automated software; however, its accuracy decreases when images differ in modality, contrast, uniformity, and resolution. This limitation could be overcome by using an external reference point; however, high-contrast agents in multi-modal imaging have not been previously reported. New methods: Here, we propose a novel multi-modal fiducial marker that contains Tungsten solution and provides high contrast in magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). The basic characteristics of this multi-modal marker were investigated by assessing major sources of image contrast in the following modalities: density and T1-, T2-relaxivity in comparison with conventional contrast agents. Results: Tungsten solution had lower T1-and T2-relaxivity and high solubility, and showed high contrast in T1-and T2-weighted MR and CT images at a high-density concentration (˜3.0 g/mL), whereas other conventional solutions did not show sufficient contrast in either CT or MRI.
Combining T1w/T2w-based myelin and fMRI-based functional network imaging recently aided a deep understanding of cortical parcellation (Glasser et al., 2016) . Positron emission tomography (PET) of neurotransmitter ligands is also useful to understand modulatory neurotransmitter systems such as monoamines (Laakso and Hietala, 2000) and multiple neurotransmitter mapping is expected to reveal characterization of cortical parcellation (Zilles and Amunts, 2009) .
In multi-modal imaging, accurate registration between different imaging modalities is mandatory to obtain integrated information on imaging objects. A widely used image registration technique is a software technique based on similar measures of voxel intensities or signals (this technique will henceforth be referred to as the "software-only" registration method) (Hill et al., 2001; Jupp and O'Brien, 2007) . The mutual information algorithm (Maes et al., 1997; Studholme et al., 1999) is commonly employed for registering multi-modal images by seeking the optimal location based on maximal mutual dependence (i.e., similarities).
However, in general, the accuracy of software-only registration is dependent on image quality, initial location, and similarities between the imaging contrasts, homogeneity and resolution, and is also rarely validated by other methods. The expected accuracy of registration depends on the size of the target tissue of interest. For example, high-level registration accuracy is needed between PET and MRI in a recently developed multi-modal cortical mapping technique (Greve et al., 2014) , since the cortical thickness is very small (minimum thickness = 1.6 mm in humans and 1.0 mm in macaques). Although the software-based registration of multi-modal brain images was finely optimized using a segmented boundary (Greve and Fischl, 2009) , the initial location and segmentation of the brain are important determinants of successful registration. In addition, since there is scarce ex-vivo evidence about the cortical distribution of neural functions, it would be useful if the accuracy of registration was validated in another way. Recent advances in hybrid scanners, such as PET/CT or PET/MRI, allow simultaneous scanning of different modalities of brain imaging. However, the accuracy of co-localization needs to be validated by other methods for quality assurance in hybrid scanners.
An alternative method of multi-modal image registration is the marker-based fiducial registration technique (Evans et al., 1991; Guo et al., 2007; Kessler et al., 1991; Kremser et al., 1997; Maurer et al., 1997 Maurer et al., , 1993 Somer et al., 2003; Wu et al., 2003) . The earlier techniques used radioactive markers for radio-imaging devices, such as PET, and did not provide high contrasts in MRI and CT. Radioactive markers are logistically more difficult to handle and both the professional personnel and scanned subjects are exposed to the substance. Here, we propose a non-radioactive imaging marker for multi-modal registration, which contains a polytungstate solution. We chose two types of polytungstate, namely sodium polytungstate (SPT) (Plewinsky and Kamps, 1984) and lithium heteropolytungstate (LST) (Patrick and Patrick, 1997) as candidate marker materials. SPT has often been used in the field of geography because its water solubility is high (density 3.1 g/mL/cm −1 3, 25°C) enough to separate it from other minerals, and it has a low toxicity (Callahan, 1987; Gregory and Johnston, 1987; Hoover et al., 1991; Plewinsky and Kamps, 1984) . LST has also often been used for a similar purpose as SPT and is commercialized as a product in liquid phase (heavy liquid, Central Chemical Consulting, WA, Australia). Tungsten, a main constituent element of SPT and LST, has a high density potential and produces reasonable contrast in X-ray and CT images, as well as having the paramagnetic property and relaxivity needed to produce MR contrasts (Lauffer, 1987; Runge et al., 1983) . In this study, we first investigated the basic characteristics of the SPT and LST solutions, particularly those needed for use as multi-modal markers, such as relaxivity, density, and tested the actual imaging contrasts in CT and MRI. We then performed imaging experiments and registration analysis on phantoms and an animal to test the applicability of these markers for multi-modal registration.
Methods
We first examined the basic characteristics of the SPT and LST solutions, such as density and relaxivity, which are important properties for CT and MRI contrast. Relaxivity refers to the rate of longitudinal (1/ T1) and transverse (1/T2) relaxation of a solution change as a function of concentration. Actual image contrasts were evaluated in the CT, MRI, and PET imaging modalities in phantom studies. We also present a point-based registration method, which is needed for registration of different modalities of images of the objects including markers. We then performed imaging experiments and registration analysis in an animal to test the applicability of these markers for multi-modal registration, particularly for cortical surface mapping, which requires highly accurate registration between PET and MRI.
Investigation of the basic characteristics of the polytungstate solutions
We investigated the density, relaxivity, and image contrast of the SPT and LST solutions in comparison to four conventional MRI contrast agents to examine their basic characteristics as markers. First, solutions of various concentrations of SPT, LST, and other MRI contrast agents were prepared. Then, image acquisitions in the MRI, CT, and transmission scan (PET/Tx) modalities were performed on tubes containing various kinds and concentrations of the prepared solutions, and the imaging contrast of the content of each tube was estimated. We describe the details of solution preparation, the imaging protocols, and the evaluation of solution contrasts in sections 2.1.1, 2.1.2, and 2.1.3, respectively.
Preparation of solutions
The solutions tested in this experiment included SPT, LST, and four conventionally used contrast agents for MRI: gadopentetate dimeglumine (Gd-DTPA), manganese chloride (MnCl 2 ), copper sulfate (CuSO 4 ), and nickel sulfate (NiSO 4 ). Table 1 shows a list of the tested substances and their density and solubility in water. LST is not listed because its main component is lithium or lithium/sodium alpha-tungstosilicate, and the composition of that material is unknown (Patrick and Patrick, 1997) .
Different concentrations of solutions were prepared for the polytungstate and conventional MRI contrast agents to be used for the phantom study (Table 2) . We determined the molar concentration of the SPT solution using the function of the mass-density (http://www. measureworks.co.jp/SPT.htm) by measuring the density of the solution. Because the chemical property of LST is not precisely known, including its molecular weight and mass-density function, we assumed that it is the same as SPT. All the prepared solutions were stored in plastic tubes (2 mL cryogenic vial, Sumitomo Backelite Co., Ltd.) to be used in imaging experiments for evaluating contrast and relaxivity. For the reference, we used pure distilled water stored in the tube.
Imaging protocols
The tubes were fixed in a tube holder and scanned using MRI, PET/ Tx, and CT. MRI was performed on a 3-Tesla scanner (MAGNETOME Prisma, Siemens AG, Erlangen, Germany) with a commercially available head and neck coil (Head/Neck 20, Siemens AG, Erlangen, Germany). The tube holder was placed inside of a water pool to obtain a sufficient proton signal to allow MRI scanning. The MRI protocol included T1-weighted MR imaging (T1w-MRI) and T2-weighted MR imaging (T2w-MRI). Additionally, inverse recovery (IR) (Meiboom and Gii, 1958; Vold et al., 1968 ) and Carr-Purcell-Meiboom-Gill (CPMG) (Carr and Purcell, 1954; Hahn, 1949) sequences were performed to measure longitudinal relaxation times and transverse relaxation times, respectively. T1w-MRI utilized the magnetization-prepared rapid acquisition with gradient echo (MPRAGE) sequence (TR = 2400 ms, TE = 2.19 ms, average of 4 scans, scan time = 22.9 min, isotropic voxel size = 1 mm, matrix = 256 × 192 × 256). T2w-MRI utilized the Sampling Perfection with Application optimized Contrast using different flip angle Evolution sequence (SPACE) (TR = 3200 ms, TE = 564 ms, scan time = 4.8 min, isotropic voxel size = 1 mm, matrix = 256 × 192 × 256). Longitudinal relaxation times were calculated from the IR sequence (TR of 2400 ms, TE of 2.19 ms, scan time = 386.1 min, voxel size = 1 × 1 × 5 mm, matrix = 256 × 256 × 1) with a variable Inversion time (TI) (TI = 21, 30, 40, 60, 80, 100, 150, 200, 400, 600, 800, 1000 (TI = 21, 30, 40, 60, 80, 100, 150, 200, 400, 600, 800, , 1200 (TI = 21, 30, 40, 60, 80, 100, 150, 200, 400, 600, 800, , 1500 (TI = 21, 30, 40, 60, 80, 100, 150, 200, 400, 600, 800, , 2000 (TI = 21, 30, 40, 60, 80, 100, 150, 200, 400, 600, 800, , 2500 , and 3000 ms). Transverse relaxation times were calculated from CPMG sequences (TR = 5000 ms, scan time = 21.5 min, voxel size = 1 × 1 x 5 mm, matrix = 256 × 256 × 1) with variable TE (TE = 8.5, 17, 25.5, 34, 42.5, 51, 59.5, 68, 76.5, 85, 93.5, 102, 110.5, 119, 127.5, and 136 ms) .
PET/Tx imaging was performed on an animal PET scanner (microPET Focus220, Siemens Co., Ltd., Knoxville, TN, USA). The spatial resolution was 1.75 mm full width at half-maximum at the center of the field of view (Sato et al., 2016) . The PET/Tx data were acquired using a CT imaging was performed on an animal cone-beam CT (R_mCT2, RIGAKU, Japan) with an X-ray flat panel detector. The data were acquired at an X-ray voltage of 90 kVp and a tube current of 0.2 mA for 2.0 min. The CT image was reconstructed using the Feldkamp conebeam algorithm (isotropic voxel size = 0.12 mm, matrix = 512 × 512 × 512).
Evaluation of solution contrasts and characteristics
We estimated the image contrast of each material with reference to water in each of the following modalities: T1w-MRI, T2w-MRI, CT, and PET/Tx. Contrast was defined as the ratio of the signal of the solution of interest to that of distilled water. The solution contrast image was generated by scaling images using the mean signal level of the distilled water image in each modality (T1w-MRI, T2w-MRI, CT, and PET/Tx).
For image calculation, we used the FSL mathematical image manipulation tool, FSLMATHS (FMRIB Image Analysis Group, Oxford, UK). After all types of images were resliced and subject to trilinear interpolation with the same voxel size (0.5 mm isotropic), the mean signal and standard deviation (SD) were calculated in a 2D dimensional region of interest (ROI) that covered 75% of the cross-sectional area of the solution in the tube. We used AMIDE (http://amide.sourceforge.net/) for ROI analysis. We also evaluated the physical characteristics of longitudinal (T1) and transverse (T2) relaxation. These values were calculated from the recovery curve of longitudinal magnetization and the decay of transverse magnetization according to the following equations:
where M z and M xy are longitudinal and transverse magnetization, M 0 is the magnetization of the thermal equilibrium state, and T 1 and T 2 are longitudinal and transverse magnetization relaxation times for the contrast agent, and TI and TE are the inversion-recovery and spin-echo times, respectively. The parameters (T 1 and M 0 ) or (T 2 and M 0 ) were estimated by the least squares method on the above curves using Microsoft Excel. The T1 relaxivity (r 1 ) and T2 relaxivity (r 2 ) are calculated based on the following equations:
where [c] is the concentration of the solution, and T 1 (w) and T 2 (w) are the longitudinal and transverse magnetization relaxation times for distilled water, which were obtained from formulas (2) and (3), similar to the corresponding solution values. The right side of Eq. (3) represents the change in the relaxation rate at different concentrations. Therefore, relaxivity, which was taken as the slope of the regression line obtained by plotting the relaxation rate on the vertical axis and solution concentration on the horizontal axis, provided a fitting range that generated a coefficient of determination of 0.9 or more. We also assessed the linear attenuation coefficient μ [1/cm], which is the rate of attenuation and alters passage of photons (γ rays, X rays) through the material. We obtained a μ [1/cm] value for each material from the XCOM database (NIST, USA, https://www.nist.gov) by entering the chemical formula and composition ratio of each solution into the database.
Application of proposed marker for multi-modal image registration
We performed PET and MRI scans on a macaque monkey to test the applicability of the proposed marker and to demonstrate the results of multi-modal image registration based on the marker. We used a macaque monkey (Macaca fascicularis, body weight 4.1 kg, male) for this experiment. The animal was maintained and handled in accordance with the recommendations of the United States National Institutes of Health. The study was approved by the Institutional Animal Care and 
Design of marker container
An important consideration for registration studies is how to fix the marker on the subject. We designed and manufactured a marker container to be used for animal experiments (Fig. 1a) . The container consists of two parts: one is spherical (outer diameter: Φ12 mm, inner diameter: Φ10 mm) and contains the tungstate solution, and the other is a prop that attaches to the surface of an object (e.g., the scalp) to support the spherical part and maintains a gap of 15.5 mm from the object's surface. We designed the container with 3D CAD software (Rhinoceros 3D v5.0, McNeel & Associates, USA), and produced it with a 3D printer (Agilista, Keyence, Osaka, Japan). Because LST liquid is easier to handle than SPT powder, we utilized LST liquid for the solution contained in the marker sphere. The animal's head was wrapped with an adhesive tape bandage to prevent skin movement. Then, five markers were attached to the surface of the adhesive tape. In addition, one marker was attached to the fixation device to confirm that there was no change in the positional relationship between the animal's head and the device during the scan (Fig. 1b) .
Animal imaging protocols
The animal was first anesthetized with an intramuscular injection of atropine sulfate (0.1 mg) and ketamine (6 mg/kg) plus dexmedetomidine (4.5 μg/kg). Local anesthetic (lidocaine pump spray, 8%) was sprayed into the animal's pharynx and larynx, and then the animal was intubated for management of respiration using a ventilator (Cato, Dräger, Germany). After confirmation of the animal's sedation and respiratory status, intravenous lines for sustained anesthesia and administration of the PET tracer were secured. The animal's body was fixed using a customized fixation device compatible with PET/MRI, and markers were attached to the animal's head and the device as described above. Anesthesia was maintained with a combination of continuously inhaled isoflurane (0.6%) and intravenous infusion of dexmedetomidine (4.5 μg/kg). The temperature of the subject was maintained at 36 ± 0.5°using heated air and a blanket. The animal underwent a transmission scan (PET/Tx) followed by an emission scan (PET/ Emission) to visualize the dopamine transporter (DAT) using the animal PET scanner. The PET/Tx scan was obtained as a single-frame 30 min scan using a 68 Ge-68 Ga line source. For the PET/Emission scan, we used (Emond et al., 1997) After PET acquisition, the animal and the accompanying devices were transferred from the PET room to the MRI room, taking care to keep the animal's head position fixed on the device and maintain the animal's anesthesia and respiratory conditions. In the same position, T2w-images were obtained using the 3-Tesla MRI scanner with the Head/Neck 20 coil. The scan parameters were: TR =3000 ms, TE =538 ms, average = 2, duration =8.5 min, isotropic voxel size = 0.8 mm, matrix = 256 × 256 × 208.
To acquire cortical surface maps, we performed another MRI experiment on a different day using the 3-Tesla scanner with a customized monkey-dedicated 24-channel coil. For T1w-MRI, we utilized the MP-RAGE sequence (TR = 2200 ms, TE = 2.2 ms, average = 3, scan time = 17.5 min, isotropic voxel size = 0.5 mm, matrix = 256 × 256 × 224). For T2w-MRI, we utilized the SPACE sequence (TR = 3200 ms, TE = 562 ms, scan time = 5.0 min, isotropic voxel size = 0.5 mm, matrix = 256 × 256 × 224).
Marker-based registration
The workflow for marker-based registration is shown in Fig. 2 . Volumes of T2w-MRI and PET/Tx image were used for co-registration because both clearly showed the marker contrast. Both volumes were resliced with high-resolution of 0.2 mm voxel size before registration. Fig. 1 . Marker design and demonstration of attachment. a) The marker was manufactured using a 3D printer and consists of a spherical part filled with a marker solution and a pillar part that generates a sufficient gap between the subject and the marker. b) The macaque's head was covered with an elastic bandage (orange), and then five markers (1˜5) were attached to the bandage surface using tape. One marker (6) was attached to the fixture for reference. OD, outer diameter; ID, inner diameter. Fig. 2 . Registration workflow. The center points of the marker in PET/Tx images were registered to the corresponding center points of the marker in MRI images using a point-based algorithm after the co-ordinates of paired markers were identified. Next, PET/Emission images were registered to MR images using a transformation matrix from PET to MRI that was calculated during this process.
T. Ose, et al. Journal of Neuroscience Methods 323 (2019) 22-31 Registration consisted of three processes. 1) Identification of co-ordinates of corresponding markers: the markers' co-ordinates were identified by calculating the centroid of the markers, and thresholding and/ or binarization was performed on the T2w-MRI and PET/Tx image in advance. The corresponding markers were identified in each imaging modality. 2) Point-based registration: the co-ordinates of corresponding markers were registered between PET /Tx and T2w-MRI using a Kabsch algorithm for point-based registration (Kabsch, 1976) . 3) Reslicing: PET/Emission images were registered to MRI using a transformation matrix from PET to MRI that was calculated during step 2. We used FSL tools and an in-house script written in Python for the analysis of image registration.
Software-only registration
To provide a reference for registration performance, we also performed a commonly used software-only registration technique between PET and MR images. For this purpose, we used volumes of T2w-MRI and PET/Emission image. The PET/Emission image was averaged across time to create a mean radioactivity image. The mean PET/ Emission image was co-registered to the T2w-MRI using rigid body registration with a mutual information-based cost function and six degrees of freedom. Before registration, the marker contrasts were manually removed from the images to eliminate the markers' effects on the software-only registration. The transformation matrix obtained above was applied to the original PET/Emission data, and registered PET/Emission data were obtained. We used a linear registration tool, FLIRT, in FSL (FMRIB's Linear Image Registration Tool, www.fmrib.ox. ac.uk/fsl/flirt/index.html).
Comparison of registration accuracy between marker-based and software-only methods
The performance of marker-based registration was investigated by comparing the results with those of a widely used software-only method. As an index of successful registration requisite, we used fiducial registration error (FRE), which is calculated as the root-meansquare distances of marker points between the registered PET/Tx and reference MRI images. FRE is one of the requisite measures for good registration, although it is limited in estimating the accuracy of registration (Fitzpatrick, 2009) .
Surface maps of the binding potential (BP) values of [ 11 C]PE2I in the registered PET/Emission images were generated by the markerbased and software-only methods. The registration was initialized using either of marker-based method or software-only method, followed by tuned optimization by the boundary-based registration (Greve and Fischl, 2009) . A BP image was calculated using region-based voxel-wise (RBV) correction as partial volume correction (PVC) (Thomas et al., 2011) and a compartment analysis of dynamic data (Ichise's Multilinear Reference Tissue Model 2: MRTM 2). For surface estimation and PVC, we used FreeSurfer 5.3.0-HCP (http://surfer.nmr.mgh.harvard.edu) (Greve et al., 2014) . The BP was smoothed along the cortical surface (Gaussian kernel function, σ = 1.25 mm). Both cortical BP-values obtained from the marker-based and software-only methods, were compared to the corresponding dopamine transporter-immunoreactivity (DAT-IR) of a previous study (Lewis et al., 2001) . In order to investigate the correlation between the BPvalue and DAT-IR, a non-parametric test (Spearman's rho test) was performed. The 20 ROIs (2, 9, 10, 11, 12, 13, 46d, 46v, 7A, 8B, 8 l, 8 m, 8 r, F1, F2, FST, INSULA, MST, V1, V2) were selected from the M132 atlas (Markov et al., 2014) , as the same regions were measured for DAT-IR in a previous study (Table 1 in Lewis et al., 2001 ). Fig. 6f shows the location of the 18 ROIs in the lateral side of the hemisphere excluding two ROIs in the medial side (9 and 10). Fig. 3 shows the relationship between contrast and concentration for the two polytungstate solutions, LST and SPT, accompanied by data obtained using conventional MRI contrast agents. A contrast-concentration curve was observed for LST and SPT in comparison to the conventional MRI contrast agents (Mn, Ni, Cu, and Gd). Both polytungstate solutions showed high contrast only at very high concentrations (> 10 2 mM) in all modalities, including T1w-MRI (Fig. 3a) , T2w-MRI (Fig. 3b) , CT (Fig. 3c) , and PET/Tx (Fig. 3d) . In contrast, the conventional MRI contrast agents showed the highest contrast in T1w- (Fig. 3a) and T2w-MRI (Fig. 3b) at very low concentrations (˜10 mM and˜10 -1 mM, respectively), and the contrast decreased sharply above those concentrations, while SPT and LST did not show any contrast at such low concentrations. LST and SPT both showed high contrast at much higher concentrations (T1w, > 10 3 ; T2w, > 10 1 -10 3 mM), concentrations at which none of the conventional MRI contrast agents dissolve in water because of their limited solubility. In the CT and PET/ Tx (Fig. 3c, d ), the contrast of the polytungstate solutions was obviously high at high concentrations (> 10 3 mM), while the conventional MRI contrast agents did not show contrast at any concentration. The results of the relaxivity and linear attenuation coefficient measurements are shown in Table 3 . Widely used MRI contrast metals, Gd and Mn, showed very high T1 relaxivity values (4.09 mM/L -1 ·s -1 and 7.33 mM/L -1 ·s -1 , respectively), but as described earlier, a linear relationship was only found at low concentrations (0.10-5.00 mM and 0.10-1.00 mM, respectively). A similar pattern of T1 relaxivity was also found for other metals, such as Cu and Ni (0.63 mM/L -1 ·s -1 and 0.62 mM/L -1 ·s -1 , respectively), in the lower range of 0.10-5.00 mM. In contrast, the T1 relaxivity of W was very small (0.43 × 10 -3 mM/L -1 ·s -1 ), and linearity was only found at very high concentrations (4.58 × 10 3 to 9.60 × 10 3 mM). A similar trend in T2 relaxivity was found for all contrast agents except Mn, which could not be robustly evaluated because of magnetic field susceptibility artifacts. The linear attenuation coefficient of the polytungstate solution in CT was 10 times (CT level: 70 keV) or 34 times (PET/Tx level: 511 keV) higher than that of conventional MRI contrast agents. Fig. 4 shows the image contrast of the polytungstate solutions compared with conventional MRI contrast agents in T1w-and T2w-MRI, CT, and PET/Tx. While the polytungstate solutions provided slightly less contrast than the conventional MRI contrast agents in T1w-MRI, they had remarkably higher contrast in the other imaging modalities (T2w-MRI, CT, PET/Tx). These findings indicate that polytungstate solutions may provide more clearly identifiable contrast in all of the investigated modalities than conventional MRI contrast agents. Note that software-only registration produces inaccurate registration whereas marker-based registration is accurate.
Results

Contrast and characteristics of tungsten solutions
T. Ose, et al. Journal of Neuroscience Methods 323 (2019) 22-31 3.2. Comparison between marker-based and software-only registration methods Fig. 5 shows the results of the software-only and marker-based registrations between the MRI (Fig. 5a ) and PET/Tx (Fig. 5b) images. When software-only registration was applied, close inspection of the PET/Tx-MRI fusion image revealed mis-registration of the marker (Fig. 5c) , while no obvious error in registration was found when marker-based registration was applied (Fig. 5d) . Table 4 shows the calculated FRE from the software-only and marker-based registrations. Because one of the markers (number 4) was outside the field of view (FOV) in PET/Tx, this marker was excluded from the FRE calculations. Thus, the FRE calculations were carried out using four markers attached to the animal's head and separately with one additional marker attached to the fixation device (five markers).
The four-marker FRE was substantially smaller in marker-based registration than in software-only registration (7.30 × 10 -8 mm vs. 2.35 mm, respectively). This was also true in the five-marker FRE (0.27 vs. 2.51, respectively). However, the five-marker FRE was larger than the fourmarker FRE in both registrations, suggesting that the location of the fifth marker (attached to the fixation device) was not the same and potentially moved relative to other markers between the MRI and PET/ Tx scans. Fig. 6 demonstrates the importance of accurate image co-registration in cortical surface mapping of PET images. Subtle, but notable, registration differences were detectable in volumetric sections (Fig. 6a , b, c) and surface maps (Fig. 6d, e) between the software-only and marker-based registrations. Note that the software-only registration yielded high BP values in the insular cortex (white circle in Fig. 6d ) but the high BP most probably originated from the misregistration of the putamen (white arrows in Fig. 6b ). In contrast, marker-based registration showed no such BP cross over the white matter surface. These subtle registration differences yield substantial differences in [
11 C]PE2I
BP in the insular area of the cortical surface maps (Fig. 6d, e) . Using the cortical ROIs of Table 1 in Lewis et al. (2001) , a comparison between [ 11 C]PE2I BP values with the relative density of DAT-IR axons revealed a significant association with marker-based registration (rho = 0.48, p = 0.03) but not with software-only registration (rho = 0.15, p = 0.52). The highest DAT-IR cortical area was the primary motor cortex (F1 in Fig. 6f) , which was evident from the high BP value of F1 with the marker-based registration (yellow circle in Fig. 6e ), but not with the software-only registration (yellow circle in Fig. 6d) , However, FRE was calculated for four markers attached to the animal's head and five markers (with an additional marker attached to the fixation device).
it must be noted that the inferior temporal cortical area showed an abnormally high BP in both registrations of the cortical surfaces (arrows in Fig. 6d,e) , potentially due to the residual partial volume and spill-in effect from the high activity in the bone marrow.
Discussion
We developed a novel fiducial marker containing polytungstate solution, which provides high contrast in multiple imaging modalities, including MRI, CT, and PET/Tx. To the best of our knowledge, no other reports have been published about such an agent having high contrast in all three of these imaging modalities. It is notable that this marker has high contrast in T1w-MRI, T2w-MRI, and CT, which is rarely seen with conventional contrast agents. This particular property seems to have been caused by the very low relaxivity of tungsten and very high solubility (hence high molecular density) of the tungsten salt. It is also notable that the marker had a particularly high density (˜3.0 g/mL) compared to any biological tissues, resulting in the marker producing significant contrast in PET/Tx, where hardly any biological tissues perform as shown in Chow et al. (2005) . Our application study also revealed that this marker containing tungsten solution facilitated more accurate image registration than conventional software-only registration, including cortical mapping, suggesting the applicability of this marker to multi-modal registration for neuroscience research.
Configuration of the marker
The marker was designed and manufactured using a 3D printer to include two parts: a container and a handling prop. The container enclosed the high-density solution to prevent evaporation. The prop prevented the marker container from directly attaching to skin or bone; otherwise, it would have been hard to distinguish the marker outline from the attached object and identify its precise position in the images. We performed phantom experiments to test the marker-based registration, and the results showed that our system worked well as long as the markers do not move relative to the subject during and between image acquisitions. The most robust and accurate method would be to directly fix the markers to the skull or bones close to the target organ (Kremser et al., 1997; Maurer et al., 1997) ; however, this would be invasive and require open surgery, and thus the marker is probably limited to use in intra-operative registration or experimental animal studies. In the current study, we wrapped self-adhesive stretchable bandages around the head and attached the markers to the bandages to prevent marker displacement due to skin movement. If the markers are directly stuck to the skin (Barnden et al., 2000; Soma et al., 2008; Somer et al., 2003; Wu et al., 2003) , then users should be aware of potential marker movement when the skin is loosened or stretched.
Characteristics of the polytungstate solution contrast
The main characteristics of the marker were that the polytungstate contained in the marker had high solubility, high density, and a high magnetic property at high concentrations. In the PET/Tx and CT, materials with high absorption rates of radio wave (γ or X rays) and high density provide high contrast. The line attenuation coefficients of the polytungstate solutions were substantially higher than those of the other solutions, which is attributable to the high solubility of the polytungstate compounds (Table 2) . In the MRI, we found that in comparison to commercially available MRI contrast agents, polytungstate produced superior signal intensity in both T1w and T2w images. The relaxation property may be generated by the polytungstate itself, but we also consider that it is related to the viscosity of the aqueous solutions (Bloembergen et al., 1948) . The viscosities of LST and SPT are approximately 12 cP and 28 cP at a density of 2.86 g/cc and 2.8 g/cc, respectively, whereas the other contrast agents investigated had viscosity levels near that of water.
Registration accuracy and cortical surface mapping
The polytungstate multi-modal marker provided an external reference system for image registration with submillimeter registration accuracy, which enabled neurobiologically relevant measures of cortical surface distribution of DAT (Fig. 6) . As a histological ground-truth, we used the density of DAT-IR axons (Lewis et al., 2001) , estimated using a DAT antibody for a DAT specific neuronal marker, and compared that with the BP-values of PE2I, which has a high affinity and selectivity for the DAT. We found a significant correlation with DAT-IR axons using marker-registration (rho = 0.48, p = 0.03), but not using software-based registration (rho = 0.15, p = 0.52), when we analyzed the DAT-IR values in the selected cortical areas in Table 1 in Lewis et al. (2001) . The area showing the greatest DAT-IR, the primary motor cortex (F1), clearly showed high BP values in the cortical surface when precise registration was achieved using the marker. These findings suggest that accurate registration is mandatory for the cortical mapping of PET data, and the marker may be helpful for identifying optimal initial locations important for fine registration.
The inferior temporal cortex had abnormally high BP values, potentially due to residual partial volume and a spill-in effect from bone marrow (Fig. 6d, e) . Thus, further optimization and development are needed for more precise parcellation and PVC of extra-brain tissues of the macaque.
Other applications
Our marker and fiducial registration system have several potential applications. First, the current multi-modal fiducial registration system can be utilized not only within a single site but also across multiple sites if an optimized method for fixing markers on subjects was developed. There are relatively few animal PET facilities available compared with CT or MRI scanners; thus, making a fiducial marker that can be attached to an animal's head may be useful to validate the co-localization of the space between different modalities of images at different facilities. In human studies, there has also been a recent attempt to collect neuroimaging data in a harmonized manner across sites to understand and predict brain diseases using big data (Casey et al., 2018) . The co-localization of the marker across sites may also provide important information to validate the undistorted space in the FOV.
Second, the marker can be used for calibration and assurance of image position across different imaging modalities. For example, such an application may be needed to test the positional accuracy of recent hybrid scanners, such as PET/CT and PET/MRI. Because the marker can be visualized in any imaging modality, users can assess the co-localizability of the marker position, which may be potentially biased by system configuration, registration errors, and image distortion. In some cases, the marker can also be used to assess distortion in the FOV of MRI due to B0 field homogeneity, and the data obtained from such a "3D distortion phantom" can be used for post-process distortion correction of target images.
Third, the current multi-modal marker may be useful when combined with image-guided stereotaxic surgery or therapeutics. There have been several markers used for this purpose, e.g., the TrueBeam system (Shiinoki et al., 2017) , oil-capsules (Gilbert et al., 2011) , gold particles (Cho et al., 2017) , cobber sulphate (Glud et al., 2017) , and gel (Medtronic® DISP 960-991 fiducial markers). However, most of these markers show contrast in only a single imaging modality, and do not show high contrast when used in multi-modal imaging. Our marker may be useful particularly when used to specifically target the localized brain area, which can often be achieved by structural-functional mapping in the brain. For example, a brain tumor can be detected by 18 F-FLT and/or 18 F-FDG PET scans while the precise location of the tracer uptake can be co-localized by high-resolution structural MRI -combined use of multi-modal information with a multi-modal marker could be useful to precisely target radiotherapy (Owen et al., 2018; Ulin et al., 2010; Zhao et al., 2015) . It could also be applied to deep brain stimulation (Chen et al., 2011; Ding et al., 2017) and transplantation of therapeutic grafts (Kikuchi et al., 2017) in deep brain areas in patients with Parkinson's disease.
Limitations of the current multi-modal marker registration
A main limitation of the current multi-modal image registration is that the accuracy of the registration relies on rigid fixation of the marker onto the target. Thus, any motion of the marker with respect to the target (e.g., head) during or between image scans (e.g., PET and MRI) can result in registration errors. In this study, since the animal was anesthetized, within-session head motion was expected to be minimal, but there was a possibility that the marker could move relative to the head. Therefore, it will be important to rigidly attach the marker to the target object and to further optimize the system in future applications.
Another limitation is that the location of the marker position may be degraded due to very high density or magnetic effects. For example, a marker with very high density may cause "streak" or "beam-hardening" artifacts in CT images, which may make it difficult to identify the marker's location accurately. However, several methods for correcting beam-hardening artifacts (Joseph and Ruth, 1997; Kyriakou et al., 2010) have been proposed and implemented in recent CT scanners. Since recent clinical PET scanners often use a CT scan for attenuation correction, the optimal density of the marker can be decreased just for the purpose of being used in CT and not in PET/Tx. In MRI, tungsten solution can cause B0 field inhomogeneity and induce susceptibility artifacts and local distortion and signal loss in the images, which could be potentially corrected by combination with B0 field map data (Jezzard and Balaban, 1995) .
Conclusions
We developed a novel fiducial multi-modal marker containing polytungstate solution. The marker is non-invasive, non-radioactive, and easy to handle, and provides high contrast in multiple medical imaging devices such as PET, CT, and MRI scanners. The use of this marker was useful for accurate cortical mapping of DAT using PET and MRI. It also revealed that the system is useful to test and validate the accuracy of software-only registration, suggesting that it is also potentially useful for validation of co-localization accuracy in recent hybrid scanners. Future studies should investigate the utility of this marker-based system in other applications, e.g., image-guided stereotaxic surgery and radiation therapy.
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